HELSINKI, Dec 12 (Reuters) - The European Medicines Agency (EMA) will allow Novo Nordisk (NOVOb.CO), opens new tab to add risk reduction for events related to kidney disease to the label of its ...

label to reflect data from the FLOW kidney outcomes trial. The FLOW trial assessed the risk reduction from Ozempic therapy in chronic kidney disease-related events. Also Read: Want To Bet On ...

The EMA approved a kidney disease–related label expansion for the blockbuster GLP-1 drug after a study showed reduced risk of death by 20%. Novo Nordisk received the go ahead to add a kidney ...

The iPack® Rx Unit Dose Packaging System streamlines the packaging and labeling of medications, ensuring healthcare providers can deliver the correct dose to the correct patient at the correct time.

Pharma-Comb Void label prevents the reuse of authentic packaging components by counterfeiters, increasing the product safety of medications while protecting patients against the administration of ...

This, he says, is a problem for everyone. Smith and his team will use the award to explore the link between heat waves and kidney disease hospitalizations. They will examine environmental factors such ...

Bogg Bag’s viral popularity isn’t slowing down just yet. The functional accessories brand founded by chief executive officer Kim Vaccarella is expanding into Target on Sunday, marking its ...

Kidney function tests are simple procedures that use either blood or urine to help identify kidney problems. There are a few types of kidney function tests, which investigate various aspects of ...